STVN Stock Analysis: Buy, Sell, or Hold?
STVN - Stevanato Group S.p.A.
$19.85
-0.35 (-1.73%)
▼
5d:
+0.86%
30d:
+8.23%
90d:
+16.76%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 04, 2026
1d
Get Alerted When STVN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: STVN shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: STVN shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$31.77
Based on 11.6% avg growth
INTRINSIC VALUE TODAY
$19.72
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: STVN is currently trading at $19.85, which is considered slightly high relative to its 30-day fair value range of $18.38 to $20.04. The stock's valuation (Forward PE: 23.8) is in line with its historical norms (22.2). At these levels, the market is pricing in 2.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, STVN is in a strong uptrend. Immediate support is located at $18.79, while resistance sits at $20.99.
Market Sentiment: STVN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $24.45 (+23.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, STVN is in a strong uptrend. Immediate support is located at $18.79, while resistance sits at $20.99.
Market Sentiment: STVN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $24.45 (+23.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$18.38 -
$20.04
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.1%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.2% below Wall St target ($24.45)
- NEUTRAL: Market pricing in 2.4% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$18.38 -
$20.04
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$18.79
Resistance Level
$20.99
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
23.82
Wall Street Target
$24.45
(+23.2%)
Revenue Growth (YoY)
6.6%
Earnings Growth (YoY)
2.9%
Profit Margin
11.8%
Valuation Premium vs History
+2.4% premium
PE vs Historical
23.8 vs 22.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.4%
(market-implied from PE analysis)
1-Year Target
$20.33
(+2%)
2-Year Target
$20.81
(+5%)
3-Year Target
$21.31
(+7%)
3-Yr Target (if PE normalizes)
(PE: 24→22)
PE COMPRESSION
$19.86
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.8, Growth: 19.1%)
$33.52
(+69%)
Base:
(SPY PE: 20.7, Growth: 19.1%)
$29.16
(+47%)
Bear:
(PE: 17.6, Growth: 19.1%)
$24.79
(+25%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (35x PE), but valuation improves significantly next year (24x PE) as earnings recover.
Trailing PE: 35.44 | Current EPS (TTM): $0.57
Bull Case
$32.48
(+64%)
Analyst growth 46.2%, PE expands to 39.0
Base Case
$29.53
(+49%)
Market implied 46.2%, PE stable at 35.4
Bear Case
$13.74
(-31%)
Severe decline -20.0%, PE contracts to 30.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 02, 2026 5:20 PM ET
Data refreshes hourly during market hours. Next update: 6:20 PM
Data refreshes hourly during market hours. Next update: 6:20 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STVN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$477 | 47 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$87 | 50 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 50 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$405 | 56 HOLD |
|
AVTR
Avantor Inc |
HOLD
21 analysts |
$15 | 56 HOLD |
